1. Bausch Health's Thermage FLX approved in Canada, boosting aesthetic business growth. 2. Approval is crucial for BHC's market expansion in non-invasive skin treatments.
The approval of Thermage FLX enhances BHC's product offerings and market position, similar to prior approvals that led to stock price increases.
The clearance is a strategic milestone, likely to attract investor interest and enhance revenue potential.
This approval supports sustained growth in BHC's aesthetics division, indicating long-term profitability based on market expansion potential.